Considerable research has focused on the anti-inflammatory and antiproliferative activities exhibited by the soy
isoflavone genistein. We previously demonstrated that
genistein suppresses
TNF-alpha-induced
NF-kappaB-dependent
IL-6 gene expression in
cancer cells by interfering with the
mitogen- and stress-activated protein kinase 1 activation pathway. However, effects of
isoflavones on immune cells, such as dendritic cells, remain largely unknown. Here we show that
genistein markedly reduces
IL-6 cytokine production and transcription in LPS-stimulated human monocyte-derived dendritic cells. More particularly, we observe that
genistein inhibits
IL-6 gene expression by modulating the
transcription factor NF-kappaB. Examination of
NF-kappaB-related events downstream of TLR4 demonstrates that
genistein affects
NF-kappaB subcellular localization and
DNA binding, although we observe only a minor inhibitory impact of
genistein on the classical LPS-induced signaling steps. Interestingly, we find that
genistein significantly increases p53
protein levels. We also show that overexpression of p53 in TLR4/MD2 HEK293T cells blocks LPS-induced
NF-kappaB-dependent gene transcription, indicating the occurrence of functional cross-talk between p53 and
NF-kappaB. Moreover, analysis of
IL-6 mRNA levels in bone marrow-derived p53 null vs wild-type dendritic cells confirms a role for p53 in the reduction of
NF-kappaB-dependent gene expression, mediated by
genistein.